Evaluation	0	9
of	11	12
antibacterial	14	26
activity	28	35
of	37	38
synthetic	40	48
aliphatic	50	58
and	60	62
aromatic	64	71
monoacylglycerols	73	89
.	90	90

The	92	94
antibacterial	96	108
activity	110	117
of	119	120
synthetic	122	130
aliphatic	132	140
and	142	144
aromatic	146	153
monoacylglycerols	155	171
(	173	173
MAGs	174	177
)	178	178
was	180	182
studied	184	190
against	192	198
two	200	202
human	204	208
pathogens	210	218
:	219	219
Staphylococcus	221	234
aureus	236	241
and	243	245
Escherichia	247	257
coli	259	262
.	263	263

The	265	267
active	269	274
compounds	276	284
inhibited	286	294
selectively	296	306
S	308	308
.	309	309
aureus	311	316
.	317	317

The	319	321
most	323	326
active	328	333
compounds	335	343
amongst	345	351
them	353	356
were	358	361
those	363	367
with	369	372
medium	374	379
size	381	384
aliphatic	386	394
chain	396	400
and	402	404
aromatic	406	413
MAGs	415	418
with	420	423
electron	425	432
withdrawing	434	444
substituents	446	457
at	459	460
the	462	464
aryl	466	469
ring	471	474
.	475	475

The	477	479
introduction	481	492
of	494	495
one	497	499
or	501	502
two	504	506
-	507	507
carbon	508	513
spacer	515	520
between	522	528
the	530	532
aryl	534	537
ring	539	542
and	544	546
the	548	550
carboxylic	552	561
function	563	570
did	572	574
not	576	578
influence	580	588
antibacterial	590	602
effectiveness	604	616
.	617	617
